Jakafi 20 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FTA03
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,090
Award facts
- Contract value 100% obligated
- $12,089.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units) with a ceiling value of $12,089.78. This firm fixed-price delivery order, awarded on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a tactical procurement of this oncology medication to support Department of Defense healthcare facilities. The award carries no set-aside designation, demonstrating the company's competitive strength in federal pharmaceutical procurement markets despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's substantial indefinite delivery contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The parent contract enables the DLA to issue firm fixed-price orders for comprehensive pharmaceutical supplies supporting military health facilities worldwide, encompassing prescription medications, biologics, and medical consumables. DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain positions it to efficiently fulfill specialized medication requirements such as this Jakafi procurement across the defense healthcare system.
Quick answers
Who was awarded contract SPE2DB25FTA03?
SPE2DB25FTA03 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FTA03 worth?
The government has obligated $12,090 on SPE2DB25FTA03.
Is contract SPE2DB25FTA03 an order under another contract?
Yes. SPE2DB25FTA03 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FTA03 competed?
The extent of competition for SPE2DB25FTA03 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award